Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Early treatment with high-dose interferon beta-1areverses cognitive and cortical plasticity deficits in multiple sclerosis.
New treatments for multiple sclerosis: at what long-term risk?
Thrombotic thrombocytopenic purpura-haemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon beta.
Characterizing cognitive function during relapse in multiple sclerosis.
CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis.
Moving to fingolimod from natalizumab in multiple sclerosis-reply.
Orientational ordering of carotenoids in myelin membranes resolved by polarized Raman microspectroscopy.
Correlation of midkine serum level with pro- and anti-inflamatory cytokines in multiple sclerosis.
Identification of a microglia phenotype supportive of remyelination.
A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.
The Effect of Contralateral Strength Training on Muscle Weakness in People With Multiple Sclerosis: A Proof-of-Concept Case Series.
Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes.
The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis.
Expression, purification, crystallization and preliminary X-ray crystallographic analysis of the extracellular olfactomedin domain of gliomedin.
MS risk allele rs1883832T is associated with decreased mRNA expression of CD40.
Seizure Drug May Help in MS Eye Disease
The primate autoimmune encephalomyelitis model; a bridge between mouse and man.
Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination.
Long-term outcome of paediatric-onset multiple sclerosis: a population-based study.
Pharmacological inhibition of caspase-2 protects axotomised retinal ganglion cells from apoptosis in adult rats.
Available evidence and outcome of off-label use of rituximab in clinical practice.
The structure and function of the S1P1 receptor.
Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation.
Pages
« first
‹ previous
…
352
353
354
355
356
357
358
359
360
…
next ›
last »